Trial record 1 of 1 for: HALO-109-202
Previous Study | Return to List | Next Study
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer (HALO-109-202)
This study is ongoing, but not recruiting participants.
First Posted: April 25, 2013
Last Update Posted: February 29, 2016
Information provided by (Responsible Party):